{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:55:39Z","timestamp":1791042939522,"version":"4.1.0"},"reference-count":9,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Crohn\u2019s & Colitis Foundation","id":[{"id":"https:\/\/ror.org\/05f2xbq60","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/ibd\/izag189","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:23:46Z","timestamp":1788521026000},"source":"Crossref","is-referenced-by-count":0,"title":["Pleiotropic anti-inflammatory effects of CB2R inverse agonism on chronic intestinal disease"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3946-1782","authenticated-orcid":false,"given":"Colm B","family":"Collins","sequence":"first","affiliation":[{"name":"School of Biomolecular and Biomedical Science, University College Dublin , Dublin,","place":["Ireland"]},{"name":"UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin , Dublin,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,3]]},"reference":[{"key":"2026100311263436800_izag189-B1","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/ibd\/izag066","article-title":"CB2R promotes T cell gut homing and exacerbates ileitis in a murine Crohn\u2019s model","volume":"32","author":"Leddy","year":"2026","journal-title":"Inflamm Bowel Dis"},{"key":"2026100311263436800_izag189-B2","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.cgh.2008.06.007","article-title":"Treatment of active Crohn\u2019s disease with MLN0002, a humanized antibody to the alpha4beta7 integrin","volume":"6","author":"Feagan","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026100311263436800_izag189-B3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa020732","article-title":"Natalizumab for active Crohn\u2019s disease","volume":"348","author":"Ghosh","year":"2003","journal-title":"N Engl J Med"},{"key":"2026100311263436800_izag189-B4","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/ecco-jcc\/jjx096","article-title":"Cannabinoid receptor-2 ameliorates inflammation in murine model of Crohn\u2019s disease","volume":"11","author":"Leinwand","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2026100311263436800_izag189-B5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/MIB.0000000000001004","article-title":"Manipulation of the endocannabinoid system in colitis: a comprehensive review","volume":"23","author":"Leinwand","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2026100311263436800_izag189-B6","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/ibd\/izad151","article-title":"The impact of cannabis use on clinical outcomes in inflammatory bowel disease: a population-based longitudinal cohort study","volume":"30","author":"Glickman","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"2026100311263436800_izag189-B7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/01.MIB.0000440982.79036.d6","article-title":"Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn\u2019s disease","volume":"20","author":"Storr","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2026100311263436800_izag189-B8","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cgh.2013.04.034","article-title":"Cannabis induces a clinical response in patients with Crohn\u2019s disease: a prospective placebo-controlled study","volume":"11","author":"Naftali","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026100311263436800_izag189-B9","doi-asserted-by":"publisher","first-page":"e0246871","DOI":"10.1371\/journal.pone.0246871","article-title":"Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: a randomized controlled trial","volume":"16","author":"Naftali","year":"2021","journal-title":"PLoS One"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izag189\/71576800\/izag189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izag189\/71576800\/izag189.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:26:39Z","timestamp":1791041199000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article\/doi\/10.1093\/ibd\/izag189\/8860286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,3]]},"references-count":9,"URL":"https:\/\/doi.org\/10.1093\/ibd\/izag189","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,3]]},"article-number":"izag189"}}